{
    "id": "dbpedia_1396_1",
    "rank": 11,
    "data": {
        "url": "https://www.freepatentsonline.com/10830775.html",
        "read_more_link": "",
        "language": "en",
        "title": "Tau kinetic measurements",
        "top_image": "",
        "meta_img": "",
        "images": [],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "<div p-id=\"p-0001\">The invention relates to in vitro methods for measuring the in vivo metabolism of tau in a subject.</div>",
        "meta_lang": "en",
        "meta_favicon": "/images/favicon_1.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.freepatentsonline.com/10830775.html",
        "text": "EP18861122014-07-09METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVOEP30669792016-09-14METHODS OF DETERMINING AMYLOID BETA TURNOVER IN BLOODWO1999017765A11999-04-15USE OF D-METHIONINE TO REDUCE THE TOXICITY OF OTOTOXIC DRUGS, NOISE, AND RADIATIONWO2003061479A12003-07-31MEASUREMENT OF PROTEIN SYNTHESIS RATES IN HUMANS AND EXPERIMENTAL SYSTEMS BY USE OF ISOTOPICALLY LABELED WATERWO2003068919A22003-08-21NON-INVASIVE METHOD FOR MEASURING RATES OF BIOSYNTHESIS OF BIOLOGICAL MOLECULES BY LABEL INCORPORATIONWO2004018997A22004-03-04METHODS AND COMPOSITIONS FOR MODULATING AMYLOID BETAWO2005081943A22005-09-09MOLECULAR FLUX RATES THROUGH CRITICAL PATHWAYS MEASURED BY STABLE ISOTOPE LABELING IN VIVO, AS BIOMARKERS OF DRUG ACTION AND DISEASE ACTIVITYWO2006017812A12006-02-16METHOD FOR MEASURING DYNAMICS OF SELF-ASSEMBLING SYSTEMS OF BIOLOGICAL MOLECULES IN VIVO AND USES FOR DISCOVERING OR EVALUATING THERAPEUTIC AGENTSWO2006081008A22006-08-03NUCLEIC ACIDS FOR APOPTOSIS OF CANCER CELLSWO2006107814A22006-10-12METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVOWO2007047323A22007-04-26METHODS TO TREAT ALZHEIMER'S DISEASE OR OTHER DISORDERS MEDIATED BY AMYLOID-BETA ACCUMULATION IN A SUBJECTWO2007106762A22007-09-20ALZHEIMER'S DISEASE BIOMARKERS AND METHODS OF USEWO2009062152A12009-05-14METHODS FOR MEASURING THE METABOLISM OF CNS DERIVED BIOMOLECULES IN VIVOWO2009076581A12009-06-18FLUCTUATIONS IN AMYLOID BETA AS A BIOMARKER FOR ALZHEIMER'S DISEASEWO2010011506A22010-01-28RISK FACTORS AND A THERAPEUTIC TARGET FOR NEURODEGENERATIVE DISORDERSWO2010056815A12010-05-20SIMULTANEOUS MEASURMENT OF THE IN VIVO METABOLISM OF ISOFORMS OF A BIOMOLECULEWO2010065878A12010-06-10METHODS FOR MEASURING CONCENTRATIONS OF BIOMOLECULESWO2011149947A22011-12-01METHODS OF DETERMINING AMYLOID BETA TURNOVER IN BLOODWO2012045882A22012-04-12PHOSPHOSPECIFIC ANTIBODIES RECOGNISING TAUWO2012075422A22012-06-07COMPOSITIONS AND METHODS FOR TREATING AMYLOID PLAQUE ASSOCIATED SYMPTOMSWO2012106363A22012-08-09TREATMENT OF TAUOPATHIESWO2012140296A12012-10-18ANTIBODY, KIT AND METHOD FOR DETERMINING AMYLOID PEPTIDESWO2013081735A12013-06-06METABOLISM OF SOD1 IN CSFWO2013082307A12013-06-06METHODS FOR MEASURING CONCENTRATIONS OF BIOMOLECULESWO2013096451A22013-06-27METHODS FOR DIAGNOSING ALZHEIMER'S DISEASEWO2014008404A12014-01-09ANTIBODIES TO TAUWO2014081851A12014-05-30METHODS OF DIAGNOSING AMYLOID PATHOLOGIES USING ANALYSIS OF AMYLOID-BETA ENRICHMENT KINETICSWO2014161890A12014-10-09Method for detecting proteinopathy-specific antibodies in a biological sampleWO2016054247A12016-04-07TAU KINETIC MEASUREMENTS"
    }
}